Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

Clinical trial NCT00771810 · COMPLETED

Trial details

NCT number: NCT00771810
Sponsor: Tarix Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Thrombocytopenia Neutropenia Lymphopenia Anemia

Start date: 2008-10-01
Primary completion: 2011-12-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.